Flagship Harbor Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.44M Sell
17,415
-241
-1% -$20K 0.07% 247
2025
Q1
$1.43M Sell
17,656
-536
-3% -$43.5K 0.08% 231
2024
Q4
$1.64M Buy
18,192
+8,938
+97% +$805K 0.09% 203
2024
Q3
$914K Buy
+9,254
New +$914K 0.05% 277
2024
Q1
$650K Buy
6,855
+641
+10% +$60.8K 0.04% 323
2023
Q4
$555K Buy
6,214
+273
+5% +$24.4K 0.04% 340
2023
Q3
$434K Buy
5,941
+577
+11% +$42.1K 0.04% 369
2023
Q2
$446K Sell
5,364
-1,083
-17% -$90.1K 0.04% 370
2023
Q1
$491K Sell
6,447
-206
-3% -$15.7K 0.05% 355
2022
Q4
$552K Sell
6,653
-172
-3% -$14.3K 0.06% 311
2022
Q3
$541K Sell
6,825
-671
-9% -$53.2K 0.06% 292
2022
Q2
$557K Buy
7,496
+1,348
+22% +$100K 0.06% 308
2022
Q1
$553K Buy
6,148
+741
+14% +$66.7K 0.05% 328
2021
Q4
$605K Sell
5,407
-479
-8% -$53.6K 0.06% 319
2021
Q3
$797K Hold
5,886
0.09% 254
2021
Q2
$797K Buy
5,886
+64
+1% +$8.67K 0.09% 255
2021
Q1
$790K Buy
5,822
+1,159
+25% +$157K 0.09% 246
2020
Q4
$656K Sell
4,663
-10,867
-70% -$1.53M 0.08% 255
2020
Q3
$1.73M Buy
15,530
+2,505
+19% +$279K 0.23% 86
2020
Q2
$1.46M Buy
13,025
+7,030
+117% +$787K 0.21% 100
2020
Q1
$464K Buy
5,995
+2,633
+78% +$204K 0.09% 210
2019
Q4
$320K Sell
3,362
-325
-9% -$30.9K 0.06% 324
2019
Q3
$281K Sell
3,687
-420
-10% -$32K 0.06% 333
2019
Q2
$360K Sell
4,107
-2,189
-35% -$192K 0.07% 270
2019
Q1
$570K Buy
6,296
+329
+6% +$29.8K 0.12% 190
2018
Q4
$428K Sell
5,967
-56
-0.9% -$4.02K 0.1% 213
2018
Q3
$570K Buy
6,023
+270
+5% +$25.6K 0.11% 208
2018
Q2
$547K Sell
5,753
-130
-2% -$12.4K 0.11% 198
2018
Q1
$494K Buy
5,883
+235
+4% +$19.7K 0.15% 174
2017
Q4
$484K Sell
5,648
-200
-3% -$17.1K 0.14% 176
2017
Q3
$516K Sell
5,848
-145
-2% -$12.8K 0.17% 155
2017
Q2
$462K Sell
5,993
-10
-0.2% -$771 0.16% 161
2017
Q1
$403K Sell
6,003
-65
-1% -$4.36K 0.15% 168
2016
Q4
$384K Buy
+6,068
New +$384K 0.17% 163